학술논문
Patient-reported outcomes (PROs) with talazoparib (TALA) plus enzalutamide (ENZA) vs. placebo (PBO) plus ENZA in men with metastatic castration-resistant prostate cancer (mCRPC): Subgroup analysis of patients with novel hormonal therapy (NHT)...
Document Type
Article
Author
De Giorgi, Ugo; Azad, Arun; Fizazi, Karim; Matsubara, Nobuaki; Saad, Fred; Joung, Jae Young; Fong, Peter C.C.; Jones, Robert J.; Zschaebitz, Stefanie; Oldenburg, Jan; Shore, Neal D.; Dunshee, Curtis; Carles, Joan; Fay, Andre P.; Cislo, Paul; Kirker, Melissa; Healy, Cynthia G.; Niyazov, Alexander; Agarwal, Neeraj
Source
Journal of Clinical Oncology; 2024 Supplement 4, Vol. 42, p116-116, 235p
Subject
Language
ISSN
0732183X